Hill staffers do not expect pharma pushback on generic drug laws
The chief minority counsel for the House of Representatives antitrust subcommittee has said he does not expect resistance from brand-name pharmaceutical companies to the legislative effort to increase access to generic versions of drugs.
Subscribe to Global Competition Review
Subscribe and start reading now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10